1. OC-032 Outcome on home parenteral nutrition: 33 years experience from a national centre. (28th May 2012) Authors: Dibb, M; Carlson, G; Bradley, A; Anderson, I; Shaffer, J; Teubner, A; Lal, S Journal: Gut Issue: Volume 61(2012)Supplement 2 Page Start: A14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OC-034 Salvage of central venous catheters in HPN catheter-related blood stream infections is safe and effective: 18 years experience from a national centre. (28th May 2012) Authors: Dibb, M; Carlson, G; Abraham, A; Shaffer, J; Teubner, A; Lal, S Journal: Gut Issue: Volume 61(2012)Supplement 2 Page Start: A14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P423 Comparative efficacy of anti-tumour necrosis factor agents and vedolizumab in ulcerative colitis. (25th January 2019) Authors: Subramanian, S; Davis, R; MacParland, P; Dodd, S; Storey, D; Probert, C; Collins, P; Skouras, T; Steel, A; Derbyshire, E; Dibb, M Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S321 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P496 Efficacy and safety of elective switching of inflammatory bowel disease patients from intravenous to subcutaneous infliximab (IFX): a multi-centre cohort study. (27th May 2021) Authors: Smith, P J; Storey, D; Gregg, B; Critchley, L; Stenson, J; Kneebone, A; Rimmer, T; Burke, S; Hussain, S; Teoh, W Y; Vazeille, S; Serna, S; Bond, A; Steel, A; Dibb, M; Collins, P; Derbyshire, E; Bodger, K; Probert, C; Verma, A Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S480 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PTH-049 Successful Reversal of High Titre Antibodies to Infliximab and Adalimumab with The Addition of Immunomodulator Therapy. (17th August 2016) Authors: Bond, A; Clark, K; Gregg, B; Collins, P; Dibb, M; Probert, C; Subramanian, S Journal: Gut Issue: Volume 65(2016)Supplement 1 Page Start: A243 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PTH-070 Patients receiving anti-tnf agents for inflammatory bowel disease: exposure to diagnostic ionising radiation and trends in imaging modalities. (22nd June 2015) Authors: Meredith, S; Dibb, M; Ellis, T; Gordon, M; Probert, C; Subramanian, S; Collins, P Journal: Gut Issue: Volume 64(2015)Supplement 1 Page Start: A437 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. PTU-335 Quality of care in the management of inflammatory bowel disease: how do patients rate their quality of care?. (22nd June 2015) Authors: Ding, WY; Baigent, A; Bunger, K; Dibb, M; Ellis, T; Gordon, M; Probert, C; Subramanian, S; Collins, P Journal: Gut Issue: Volume 64(2015)Supplement 1 Page Start: A209 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. PWE-068 Correlation of a patient reported single item global disease rating scale to clinical and biological markers of disease activity. (22nd June 2015) Authors: Rimmer, M; Asher, R; Jackson, R; Race, G; Collins, P; Dibb, M; Probert, C; Rhodes, J; Subramanian, S Journal: Gut Issue: Volume 64(2015)Supplement 1 Page Start: A241 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. PWE-078 Mean Corpuscular Volume But Not Lymphocyte Count Is A Predictor Of Thiopurine Dose Adequacy And Toxicity. (9th June 2014) Authors: Kneebone, A; Poon, SS; Asher, R; Jackson, R; Gregg, B; Kerr, S; Collins, P; Probert, C; Subramanian, S; Dibb, M Journal: Gut Issue: Volume 63(2014)Supplement 1 Page Start: A157 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. PWE-100 Increasing Weight And Body Mass Index Adversely Affect Thioguanine Nucleotide Levels In Inflammatory Bowel Disease. (9th June 2014) Authors: Subramanian, S; Poon, S; Kneebone, A; Asher, R; Jackson, R; Gregg, B; Collins, P; Probert, C; Dibb, M Journal: Gut Issue: Volume 63(2014)Supplement 1 Page Start: A168 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗